Clinical Trial Update: Cyclosporine in Acute Myocardial Infarction Complicated by Cardiogenic Shock [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating cyclosporine in acute myocardial infarction complicated by cardiogenic shock has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiogenic Shock
• Myocardial Infarction

Drugs mentioned

• CYCLOSPORINE (cyclosporine)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Acute Myocardial Infarction | Phase 2 | Status: WITHDRAWN